ID   ITSN1_RAT               Reviewed;        1713 AA.
AC   Q9WVE9; D3ZV52; F1M823; Q9WVE1;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   05-DEC-2018, sequence version 2.
DT   24-JUL-2024, entry version 182.
DE   RecName: Full=Intersectin-1 {ECO:0000305};
DE   AltName: Full=EH domain and SH3 domain regulator of endocytosis 1;
GN   Name=Itsn1 {ECO:0000312|RGD:2935};
GN   Synonyms=Ehsh1 {ECO:0000303|PubMed:10373452}, Itsn;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), SUBCELLULAR LOCATION,
RP   INTERACTION WITH DYNAMIN; SNAP23 AND SNAP25, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=10373452; DOI=10.1074/jbc.274.26.18446;
RA   Okamoto M., Schoch S., Suedhof T.C.;
RT   "EHSH1/intersectin, a protein that contains EH and SH3 domains and binds to
RT   dynamin and SNAP-25. A protein connection between exocytosis and
RT   endocytosis?";
RL   J. Biol. Chem. 274:18446-18454(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH WASL.
RX   PubMed=11584276; DOI=10.1038/ncb1001-927;
RA   Hussain N.K., Jenna S., Glogauer M., Quinn C.C., Wasiak S., Guipponi M.,
RA   Antonarakis S.E., Kay B.K., Stossel T.P., Lamarche-Vane N., McPherson P.S.;
RT   "Endocytic protein intersectin-l regulates actin assembly via Cdc42 and N-
RT   WASP.";
RL   Nat. Cell Biol. 3:927-932(2001).
RN   [5]
RP   FUNCTION, INTERACTION WITH FCHO2, IDENTIFICATION BY MASS SPECTROMETRY,
RP   IDENTIFICATION IN A COMPLEX WITH FCHO2; DNM1 AND EPS15, SUBCELLULAR
RP   LOCATION, AND SUBUNIT.
RX   PubMed=20448150; DOI=10.1126/science.1188462;
RA   Henne W.M., Boucrot E., Meinecke M., Evergren E., Vallis Y., Mittal R.,
RA   McMahon H.T.;
RT   "FCHo proteins are nucleators of clathrin-mediated endocytosis.";
RL   Science 328:1281-1284(2010).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-203; SER-334; SER-335;
RP   SER-685; SER-894; SER-896; SER-970; SER-1129 AND THR-1136, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [7]
RP   FUNCTION.
RX   PubMed=23633571; DOI=10.1073/pnas.1219234110;
RA   Sakaba T., Kononenko N.L., Bacetic J., Pechstein A., Schmoranzer J.,
RA   Yao L., Barth H., Shupliakov O., Kobler O., Aktories K., Haucke V.;
RT   "Fast neurotransmitter release regulated by the endocytic scaffold
RT   intersectin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:8266-8271(2013).
RN   [8]
RP   INTERACTION WITH PRRT2, AND SUBCELLULAR LOCATION.
RX   PubMed=26797119; DOI=10.1074/jbc.m115.683888;
RA   Rossi P., Sterlini B., Castroflorio E., Marte A., Onofri F., Valtorta F.,
RA   Maragliano L., Corradi A., Benfenati F.;
RT   "A Novel Topology of Proline-rich Transmembrane Protein 2 (PRRT2): hints
RT   for an intracellular function at the synapse.";
RL   J. Biol. Chem. 291:6111-6123(2016).
CC   -!- FUNCTION: Adapter protein that provides a link between the endocytic
CC       membrane traffic and the actin assembly machinery. Acts as a guanine
CC       nucleotide exchange factor (GEF) for CDC42, and thereby stimulates
CC       actin nucleation mediated by WASL and the ARP2/3 complex (By
CC       similarity). Plays a role in the assembly and maturation of clathrin-
CC       coated vesicles (PubMed:20448150). Recruits FCHSD2 to clathrin-coated
CC       pits (By similarity). Involved in endocytosis of activated EGFR, and
CC       probably also other growth factor receptors (By similarity). Involved
CC       in endocytosis of integrin beta-1 (ITGB1) and transferrin receptor
CC       (TFR); internalization of ITGB1 as DAB2-dependent cargo but not TFR may
CC       involve association with DAB2 (By similarity). Promotes ubiquitination
CC       and subsequent degradation of EGFR, and thereby contributes to the
CC       down-regulation of EGFR-dependent signaling pathways. In chromaffin
CC       cells, required for normal exocytosis of catecholamines (By
CC       similarity). Required for rapid replenishment of release-ready synaptic
CC       vesicles at presynaptic active zones (PubMed:23633571). Inhibits
CC       ARHGAP31 activity toward RAC1 (By similarity).
CC       {ECO:0000250|UniProtKB:Q15811, ECO:0000250|UniProtKB:Q9Z0R4,
CC       ECO:0000269|PubMed:20448150, ECO:0000269|PubMed:23633571}.
CC   -!- FUNCTION: [Isoform 1]: Plays a role in synaptic vesicle endocytosis in
CC       brain neurons. {ECO:0000250|UniProtKB:Q9Z0R4}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00041};
CC   -!- SUBUNIT: Interacts (via DH domain) with CDC42. Interacts (via SH3
CC       domain 1) with WASL (By similarity). Interacts with dynamin, SNAP25 and
CC       SNAP23 (PubMed:10373452). Interacts with clathrin-associated proteins
CC       and other components of the endocytic machinery, such as SPIN90, EPS15,
CC       EPN1, EPN2, STON2, FCHO1, FCHO2 and DAB2 (PubMed:20448150). Interacts
CC       (via SH3 domains) with REPS1 and SGIP1. Interacts with ARHGAP31.
CC       Interacts with ADAM15 (By similarity). Interacts with PRRT2
CC       (PubMed:26797119). Interacts (via SH3 domain 4) with FCHSD2 (via SH3
CC       domain 2). Interacts (via SH3 domain 1) with DENND2B (By similarity).
CC       Interacts (via SH3 domains) with CBL (By similarity). Isoform 2:
CC       Interacts with CBL and DNM1. Isoform 2: Interacts with LMNA. Isoform 2:
CC       Interacts with importin subunit KPNA1; this is likely to mediate its
CC       import into the nucleus (By similarity). Interacts with DNM2 (By
CC       similarity). {ECO:0000250|UniProtKB:Q15811,
CC       ECO:0000250|UniProtKB:Q9Z0R4, ECO:0000269|PubMed:10373452,
CC       ECO:0000269|PubMed:20448150, ECO:0000269|PubMed:26797119}.
CC   -!- SUBCELLULAR LOCATION: Endomembrane system
CC       {ECO:0000250|UniProtKB:Q15811}. Synapse, synaptosome
CC       {ECO:0000269|PubMed:10373452, ECO:0000269|PubMed:26797119}. Cell
CC       projection, lamellipodium {ECO:0000250|UniProtKB:Q15811}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q15811}. Membrane, clathrin-coated pit
CC       {ECO:0000269|PubMed:11584276, ECO:0000269|PubMed:20448150}. Recycling
CC       endosome {ECO:0000250|UniProtKB:Q15811}. Endosome
CC       {ECO:0000250|UniProtKB:Q9Z0R4}. Cytoplasmic vesicle
CC       {ECO:0000250|UniProtKB:Q9Z0R4}. Note=Colocalizes with SGIP1 at the
CC       plasma membrane in structures corresponding most probably to clathrin-
CC       coated pits. Colocalizes with RAB13 on cytoplasmic vesicles that are
CC       most likely recycling endosomes. {ECO:0000250|UniProtKB:Q15811}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cytoplasm
CC       {ECO:0000250|UniProtKB:Q15811}. Nucleus envelope
CC       {ECO:0000250|UniProtKB:Q15811}. Note=Shuttles between the cytoplasm and
CC       nucleus in an XPO1/CRM1-dependent manner.
CC       {ECO:0000250|UniProtKB:Q15811}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9WVE9-3; Sequence=Displayed;
CC       Name=2; Synonyms=ITSN-s {ECO:0000250|UniProtKB:Q15811};
CC         IsoId=Q9WVE9-1; Sequence=VSP_059959, VSP_059961;
CC       Name=3;
CC         IsoId=Q9WVE9-2; Sequence=VSP_059959, VSP_059960, VSP_059961;
CC   -!- TISSUE SPECIFICITY: Detected in brain, spleen, lung, liver and heart
CC       (at protein level). Ubiquitous. Detected in brain, spleen, lung, liver,
CC       skeletal muscle and kidney. {ECO:0000269|PubMed:10373452}.
CC   -!- DOMAIN: SH3-1 and SH3-4 bind to ARHGAP31 (By similarity). SH3-3, SH3-4
CC       and SH3-5, but not SH3-1 and SH3-2 domains, bind to dynamin.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The KLERQ domain binds to SNAP-25 and SNAP-23.
CC   -!- DOMAIN: In an autoinhibited form the SH3 domain 5 may bind
CC       intramolecularly to the DH domain, thus blocking the CDC42-binding
CC       site. {ECO:0000250|UniProtKB:Q9Z0R4}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF127798; AAD30271.1; -; mRNA.
DR   EMBL; AF132672; AAD31026.1; -; mRNA.
DR   EMBL; AC123507; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC142009; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH473989; EDM10741.1; -; Genomic_DNA.
DR   RefSeq; NP_001129568.1; NM_001136096.1. [Q9WVE9-3]
DR   RefSeq; NP_062100.1; NM_019227.1. [Q9WVE9-1]
DR   PDB; 3HS9; X-ray; 2.15 A; P=844-855.
DR   PDBsum; 3HS9; -.
DR   AlphaFoldDB; Q9WVE9; -.
DR   SMR; Q9WVE9; -.
DR   BioGRID; 248132; 5.
DR   IntAct; Q9WVE9; 4.
DR   MINT; Q9WVE9; -.
DR   STRING; 10116.ENSRNOP00000044773; -.
DR   iPTMnet; Q9WVE9; -.
DR   PhosphoSitePlus; Q9WVE9; -.
DR   PaxDb; 10116-ENSRNOP00000045513; -.
DR   Ensembl; ENSRNOT00000096792.1; ENSRNOP00000095645.1; ENSRNOG00000002001.9. [Q9WVE9-3]
DR   GeneID; 29491; -.
DR   KEGG; rno:29491; -.
DR   UCSC; RGD:2935; rat. [Q9WVE9-3]
DR   AGR; RGD:2935; -.
DR   CTD; 6453; -.
DR   RGD; 2935; Itsn1.
DR   eggNOG; KOG1029; Eukaryota.
DR   GeneTree; ENSGT00940000157065; -.
DR   HOGENOM; CLU_002819_2_0_1; -.
DR   InParanoid; Q9WVE9; -.
DR   OrthoDB; 2910300at2759; -.
DR   PhylomeDB; Q9WVE9; -.
DR   Reactome; R-RNO-193648; NRAGE signals death through JNK.
DR   Reactome; R-RNO-3928662; EPHB-mediated forward signaling.
DR   Reactome; R-RNO-416482; G alpha (12/13) signalling events.
DR   Reactome; R-RNO-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-RNO-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-RNO-9013148; CDC42 GTPase cycle.
DR   Reactome; R-RNO-9013406; RHOQ GTPase cycle.
DR   Reactome; R-RNO-9013408; RHOG GTPase cycle.
DR   EvolutionaryTrace; Q9WVE9; -.
DR   PRO; PR:Q9WVE9; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Proteomes; UP000234681; Chromosome 11.
DR   Bgee; ENSRNOG00000002001; Expressed in skeletal muscle tissue and 18 other cell types or tissues.
DR   GO; GO:0097440; C:apical dendrite; IDA:RGD.
DR   GO; GO:0044305; C:calyx of Held; ISO:RGD.
DR   GO; GO:0005905; C:clathrin-coated pit; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0043197; C:dendritic spine; IDA:RGD.
DR   GO; GO:0030139; C:endocytic vesicle; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0097708; C:intracellular vesicle; IDA:RGD.
DR   GO; GO:0030027; C:lamellipodium; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005635; C:nuclear envelope; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0098871; C:postsynaptic actin cytoskeleton; IDA:SynGO.
DR   GO; GO:0098843; C:postsynaptic endocytic zone; IDA:SynGO.
DR   GO; GO:0098833; C:presynaptic endocytic zone; ISO:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; IBA:GO_Central.
DR   GO; GO:0055037; C:recycling endosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0043195; C:terminal bouton; HDA:ParkinsonsUK-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IEA:InterPro.
DR   GO; GO:0019209; F:kinase activator activity; ISO:RGD.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0070064; F:proline-rich region binding; ISO:RGD.
DR   GO; GO:0150007; P:clathrin-dependent synaptic vesicle endocytosis; IBA:GO_Central.
DR   GO; GO:0016197; P:endosomal transport; IBA:GO_Central.
DR   GO; GO:0006887; P:exocytosis; IEA:UniProtKB-KW.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:0051402; P:neuron apoptotic process; ISO:RGD.
DR   GO; GO:2001288; P:positive regulation of caveolin-mediated endocytosis; IMP:RGD.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; IMP:RGD.
DR   GO; GO:0060124; P:positive regulation of growth hormone secretion; IMP:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0008104; P:protein localization; ISO:RGD.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:1905274; P:regulation of modification of postsynaptic actin cytoskeleton; IDA:SynGO.
DR   GO; GO:0099175; P:regulation of postsynapse organization; IDA:SynGO.
DR   GO; GO:0007264; P:small GTPase-mediated signal transduction; ISO:RGD.
DR   GO; GO:0048488; P:synaptic vesicle endocytosis; ISO:RGD.
DR   CDD; cd08375; C2_Intersectin; 1.
DR   CDD; cd00052; EH; 2.
DR   CDD; cd13264; PH_ITSN; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   CDD; cd11987; SH3_Intersectin1_1; 1.
DR   CDD; cd11989; SH3_Intersectin1_2; 1.
DR   CDD; cd11993; SH3_Intersectin1_4; 1.
DR   CDD; cd11995; SH3_Intersectin1_5; 1.
DR   Gene3D; 2.60.40.150; C2 domain; 1.
DR   Gene3D; 1.20.900.10; Dbl homology (DH) domain; 1.
DR   Gene3D; 1.10.238.10; EF-hand; 2.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 5.
DR   InterPro; IPR000008; C2_dom.
DR   InterPro; IPR035892; C2_domain_sf.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR000261; EH_dom.
DR   InterPro; IPR051480; Endocytic_GEF_Adapter.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR032140; INTAP.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR46006:SF9; INTERSECTIN-2 ISOFORM X1; 1.
DR   PANTHER; PTHR46006; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR AT 64C, ISOFORM A; 1.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF12763; EF-hand_4; 2.
DR   Pfam; PF16617; INTAP; 1.
DR   Pfam; PF16652; PH_13; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   Pfam; PF00018; SH3_1; 2.
DR   Pfam; PF07653; SH3_2; 2.
DR   Pfam; PF14604; SH3_9; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00054; EFh; 2.
DR   SMART; SM00027; EH; 2.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SMART; SM00326; SH3; 5.
DR   SUPFAM; SSF49562; C2 domain (Calcium/lipid-binding domain, CaLB); 1.
DR   SUPFAM; SSF48065; DBL homology domain (DH-domain); 1.
DR   SUPFAM; SSF47473; EF-hand; 2.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF50044; SH3-domain; 5.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 2.
DR   PROSITE; PS50031; EH; 2.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50002; SH3; 5.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell membrane;
KW   Cell projection; Coated pit; Coiled coil; Cytoplasm; Cytoplasmic vesicle;
KW   Endocytosis; Endosome; Exocytosis; Membrane; Metal-binding; Nucleus;
KW   Phosphoprotein; Protein transport; Reference proteome; Repeat; SH3 domain;
KW   Synapse; Synaptosome; Transport.
FT   CHAIN           1..1713
FT                   /note="Intersectin-1"
FT                   /id="PRO_0000080959"
FT   DOMAIN          21..109
FT                   /note="EH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00077"
FT   DOMAIN          53..88
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          221..310
FT                   /note="EH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00077"
FT   DOMAIN          254..289
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          737..798
FT                   /note="SH3 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          905..963
FT                   /note="SH3 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          994..1052
FT                   /note="SH3 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          1066..1130
FT                   /note="SH3 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          1147..1206
FT                   /note="SH3 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          1229..1415
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          1454..1563
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          1571..1687
FT                   /note="C2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   REGION          310..354
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          326..702
FT                   /note="KLERQ"
FT   REGION          629..723
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          826..862
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1066..1130
FT                   /note="Required for interaction with FCHSD2"
FT                   /evidence="ECO:0000250|UniProtKB:Q15811"
FT   COILED          351..670
FT                   /evidence="ECO:0000255"
FT   MOTIF           1096..1119
FT                   /note="Bipartite nuclear localization signal; in isoform 2"
FT                   /evidence="ECO:0000250|UniProtKB:Q15811"
FT   COMPBIAS        314..329
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        330..354
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        629..709
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        829..862
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         66
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         68
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         70
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         72
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         77
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         267
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         269
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         271
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         273
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         278
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         1659
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1662
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   BINDING         1665
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00041"
FT   MOD_RES         203
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         318
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0R4"
FT   MOD_RES         334
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         335
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         685
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         889
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0R4"
FT   MOD_RES         893
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15811"
FT   MOD_RES         894
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         896
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         970
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         976
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9Z0R4"
FT   MOD_RES         987
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15811"
FT   MOD_RES         1129
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1136
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   VAR_SEQ         766
FT                   /note="V -> VKGEWV (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_059959"
FT   VAR_SEQ         998..1068
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_059960"
FT   VAR_SEQ         1213..1713
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_059961"
FT   CONFLICT        781
FT                   /note="L -> P (in Ref. 1; AAD30271/AAD31026)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1019
FT                   /note="D -> H (in Ref. 1; AAD30271)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1065
FT                   /note="G -> E (in Ref. 1; AAD30271)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1713 AA;  194197 MW;  DF5ED07492F716BA CRC64;
     MAQFPTPFGG SLDIWAITVE ERAKHDQQFQ SLKPISGFIT GDQARNFFFQ SGLPQPVLAQ
     IWALADMNKD GRMDQVEFSI AMKLIKLKLQ GYQLPPALPP VMKQQPAAIS SAPAFGIGGM
     AGMPPLTAVA PVPMGSIPVV GMSPPLVSSV PQAAVPPLAN GAPPVIQPLP AFAHPAATLP
     KSSSFSRSGP GSQLNTKLQK AQSFDVASAP AAAEWAVPQS SRLKYRQLFN SHDKTMSGHL
     TGPQARTILM QSSLPQAQLA SIWNLSDIDQ DGKLTAEEFI LAMHLIDVAM SGQPLPPVLP
     PEYIPPSFRR VRSGSGMSVI SSSSADQRLP EEPSSEDEQQ VEKKLPVTFE DKKRENFERG
     NLELEKRRQA LLEQQRKEQE RLAQLERAEQ ERKERERQEQ ERKRQLELEK QLEKQRELER
     QREEERRKEI ERREAAKREL ERQRQLEWER NRRQELLTQR NKDQEGIVVL KARRKTLEFE
     LEALNDKKHQ LEGKLQDIRC RLATQRQEIE STNKSRELRI AEITHLQQQL QESQQMLGRL
     IPEKQILSDQ LKQVQQNSLH RDSLLTLKRA LEAKELARQQ LREQLDEVEK ETRSKLQEID
     VFNNQLKELR EIHSKQQLQK QRSIEAERLK QKEQERKSLE LEKQKEEGQR RVQERDKQWQ
     EHVQQEEQQR PRKPHEEDKL KREDSVKKKE AEERAKPEVQ DKQSRLFHPH QEPAKPAQAP
     WPTTEKGPLT ISAQESAKVV YYRALYPFES RSHDEITIQP GDIVMVDESQ TGEPGWLGGE
     LKGKTGWFPA NYAEKIPENE IPTPAKPVTD LTSAPAPKLA LRETPAPLPV TSSEPSTTPN
     NWADFSSTWP SSTNEKPETD NWDTWAAQPS LTVPSAGQLR QRSAFTPATA TGSSPSPVLG
     QGEKVEGLQA QALYPWRAKK DNHLNFNKSD VITVLEQQDM WWFGEVQGQK GWFPKSYVKL
     ISGPVRKSTS IDTGPTEAPS SLKRVASPAA KPAIPGEEFV AMYTYESSEH GDLTFQQGDV
     IVVTKKDGDW WTGTVGETSG VFPSNYVRLK DSEGSGTAGK TGSLGKKPEI AQVIASYTAT
     GPEQLTLAPG QLILIRKKNP GGWWEGELQA RGKKRQIGWF PANYVKLLSP GTSKITPTEL
     PKTAVQPAVC QVIGMYDYTA QNDDELAFSK GQIINVLSKE DPDWWKGEVS GQVGLFPSNY
     VKLTTDMDPS QQWCSDLHLL DMLTPTERKR QGYIHELIVT EENYVNDLQL VTEIFQKPLT
     ESELLTEKEV AMIFVNWKEL IMCNIKLLKA LRVRKKMSGE KMPVKMIGDI LSAQLPHMQP
     YIRFCSCQLN GAALIQQKTD EAPDFKEFVK RLAMDPRCKG MPLSSFILKP MQRVTRYPLI
     IKNILENTPE NHPDHSHLKH ALEKAEELCS QVNEGVREKE NSDRLEWIQA HVQCEGLSEQ
     LVFNSVTNCL GPRKFLHSGK LYKAKSNKEL YGFLFNDFLL LTQITKPLGS SSTDKVFSPK
     SNLQYKMYKT PIFLNEVLVK LPTDPSGDEP IFHISHIDRV YTLRAESINE RTAWVQKIKA
     ASELYIETEK KKREKAYLVR SQRATGIGRL MVNVVEGIEL KPCRSHGKSN PYCEVTMGSQ
     CHITKTIQDT LNPKWNSNCQ FFIRDLEQEV LCITVFERDQ FSPDDFLGRT EIRVADIKKD
     QGSKGPVTKC LLLHEVPTGE IVVRLDLQLF DEP
//
